Related Experiment Video
Updated: May 19, 2026

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues
Published on: May 8, 2016
Chemerin/ChemerinR1 axis and inflammation-related diseases
Jun Li1,2,3, Changhao Mao1,3,4, Ke Li1,2,3
1School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
The Chemerin/ChemerinR1 axis is crucial in inflammation-related diseases, impacting their onset and progression. Targeting this axis offers potential therapeutic strategies and diagnostic biomarkers for conditions like cardiovascular and autoimmune diseases.
Area of Science:
- Biomedical Science
- Molecular Biology
- Immunology
Background:
- Inflammation-related diseases pose significant global health challenges.
- The Chemerin/ChemerinR1 axis, involving an adipokine and its GPCR, regulates inflammation, metabolism, and immune responses.
- Understanding this axis is vital for developing novel therapeutic targets.
Purpose of the Study:
- To review the molecular mechanisms of the Chemerin/ChemerinR1 axis in inflammation.
- To explore the role of this axis in various inflammation-related diseases.
- To highlight its potential as a therapeutic target and diagnostic biomarker.
Main Methods:
- Comprehensive literature review of studies on the Chemerin/ChemerinR1 axis.
- Analysis of signaling pathways activated by Chemerin/ChemerinR1.
- Examination of the axis's involvement in diverse inflammatory conditions.
Main Results:
- The Chemerin/ChemerinR1 axis activates MAPK, PI3K/Akt, and NF-κB pathways, driving inflammation.
- This axis is implicated in hypertension, atherosclerosis, stroke, obesity, rheumatoid arthritis, and inflammatory bowel disease.
- The axis serves as a potential biomarker for early diagnosis and treatment monitoring.
Conclusions:
- The Chemerin/ChemerinR1 axis is a key regulator in inflammation-related diseases.
- Targeting this axis presents a promising therapeutic strategy for vascular and other inflammatory conditions.
- Its role as a biomarker aids in disease management and therapeutic evaluation.
Related Concept Videos
Inflammatory Bowel Disease III: Crohn's Disease
Chronic Inflammation: Introduction
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease II: Ulcerative Colitis
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

